RecruitingPhase 3NCT05351346

Genotype-guided Treatment in DLBCL

Studying Diffuse large B-cell lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ruijin Hospital
Intervention
Rituximab(drug)
Enrollment
1100 enrolled
Eligibility
18-80 years · All sexes
Timeline
2022 – 2026

Study locations (1)

Collaborators

West China Hospital, Sichuan · Qilu Hospital of Shandong University · Shanghai Jiao Tong University Affiliated Sixth People's Hospital · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · The Second Hospital of Anhui Medical University · Zhongda Hospital · The First Affiliated Hospital of Soochow University · China-Japan Friendship Hospital · Tongji Hospital · Beijing Hospital · The Second Affiliated Hospital of Dalian Medical University · Zhujiang Hospital · The First Affiliated Hospital of Anhui Medical University North District · Hunan Cancer Hospital · Liaoning Cancer Hospital & Institute · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Cancer Hospital Affiliated to Xinjiang Medical University · The First Affiliated Hospital of Xiamen University · The First Affiliated Hospital of Nanchang University · LanZhou University · Central South University · The Affiliated Hospital of Xuzhou Medical University · Yunnan Cancer Hospital · Henan Cancer Hospital · Fujian Medical University Union Hospital · The First Hospital of Jilin University · The First Affiliated Hospital of Anhui Medical University · Gansu Cancer Hospital · The First Affiliated Hospital of University of Science and Technology of China · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Second Affiliated Hospital of Xi'an Jiaotong University · First Affiliated Hospital Xi'an Jiaotong University · RenJi Hospital · Shandong Cancer Hospital and Institute · Affiliated Cancer Hospital of Harbin Medical University · First Affiliated Hospital of Chongqing Medical University · Fudan University · Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Pekcing Union Medical College · Affiliated Hospital of Nantong University · Yunnan First People's Hospital · Shanxi Province Cancer Hospital · Fifth Affiliated Hospital of Guangzhou Medical University · Beijing Tongren Hospital · First Affiliated Hospital of Harbin Medical University · The Third Affiliated Hospital of Wenzhou Medical University · Harbin Institute of Hematology · The First Affiliated Hospital of Guangzhou Medical University · Affiliated Hospital of Guilin Medical College · Air Force Military Medical University, China · Affiliated Zhongshan Hospital of Dalian University · Yantai Yuhuangding Hospital · The First Affiliated Hospital of Zhengzhou University · Peking University Third Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05351346 on ClinicalTrials.gov

Other trials for Diffuse large B-cell lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Diffuse large B-cell lymphoma →

← Back to all trials